Traditional cancer therapies, including radiotherapy, targeted therapy, and biological agent therapy, have markedly improved patient outcomes yet fall short of achieving complete and durable eradication of cancer cells. These modalities typically provide only temporary tumor suppression, as malignant cells readily develop drug resistance, ultimately limiting long-term efficacy. Consequently, overall 5-year survival rates for many cancers have remained below 60%, highlighting a critical unmet need for more effective treatment strategies. This research article introduces the novel concept of resonance cancer elimination (Neutrino ablation [Neu-WES] Framework), a promising approach that leverages specific wavelengths and tuned resonance frequencies to selectively and precisely target cancer cells. By exploiting the unique biophysical properties of malignant cells, this method aims to induce resonance-mediated disruption of their structural integrity or essential metabolic processes, leading to their complete and permanent destruction at the tumor site while sparing healthy tissues. We propose a new technological and conceptual framework for resonance-based cancer therapy (Neutrino ablation [Neu-WES]) that has the potential to complement or surpass conventional treatments. This research lays the theoretical foundation for resonance cancer elimination and outlines new pathways for its future experimental validation and clinical translation. This innovative(Neu-WES) approach represents a paradigm shift toward more accurate, resistance-proof, and minimally invasive cancer eradication.
No takes yet. Share an insight, caveat, or question.
LIE Chun Pong (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: